Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Three Dosing Schedules of Oral Rigosertib in MDS Patients
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis
- Status
- COMPLETED
- Phase
- PHASE2
Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- N/A
Occupational Status and Hematological Disease
- Status
- COMPLETED
- Phase
- N/A
Adoptive Transfer of Haplo-identical DLI for AML and MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- N/A
The Effect of Combination Ultra Q10 and L-carnitine on the Course of Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE4
Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
- Status
- COMPLETED
- Phase
- PHASE1
Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of 3 Different Doses of IV Busulfan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
- Status
- COMPLETED
- Phase
- PHASE1